Bettina M. Cockroft - May 3, 2023 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Stock symbol
CNSP
Transactions as of
May 3, 2023
Transactions value $
$0
Form type
3
Date filed
5/9/2023, 05:10 PM
Previous filing
Jun 13, 2022
Next filing
Aug 10, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney